BeiGene Balance Sheet Analysis From 2010 to 2024

BGNE Stock

USD 130.94 1.42 1.10%

Most indicators from BeiGene's financial ratios are interrelated and interconnected. However, analyzing financial ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of financial ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out BeiGene Valuation and BeiGene Correlation analysis.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.

Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out BeiGene Valuation and BeiGene Correlation analysis.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.

	2021	2022	2023	2024 (projected)
Interest Expense	15.8M	52.5M	37.4M	39.2M
Depreciation And Amortization	750K	751K	87.7M	92.1M

Interest Expense Depreciation And Amortization

BeiGene fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.86	0.61	0.85	1.0	0.95	0.94	0.71	0.68	-0.92	-0.82	0.88	0.92	0.77	-0.3	0.65	0.77	0.99	0.87	0.9	0.65	0.94	0.93	0.9	0.92	0.71
Short Long Term Debt Total	0.86		0.84	0.96	0.83	0.86	0.95	0.96	0.41	-0.89	-0.99	0.99	0.94	0.96	-0.45	0.32	0.73	0.8	0.96	0.89	0.32	0.83	0.96	0.99	0.97	0.96
Other Current Liab	0.61	0.84		0.92	0.58	0.7	0.82	0.94	0.1	-0.71	-0.85	0.82	0.77	0.95	-0.05	0.29	0.52	0.54	0.81	0.64	0.05	0.45	0.82	0.82	0.82	0.92
Total Current Liabilities	0.85	0.96	0.92		0.83	0.91	0.97	0.95	0.38	-0.88	-0.95	0.96	0.92	0.98	-0.22	0.42	0.65	0.8	0.93	0.84	0.36	0.73	0.95	0.97	0.97	0.94
Total Stockholder Equity	1.0	0.83	0.58	0.83		0.95	0.93	0.68	0.7	-0.92	-0.79	0.87	0.91	0.74	-0.28	0.68	0.76	0.99	0.85	0.88	0.68	0.94	0.92	0.89	0.91	0.68
Other Liab	0.95	0.86	0.7	0.91	0.95		0.96	0.75	0.64	-0.87	-0.82	0.89	0.89	0.81	-0.14	0.63	0.68	0.95	0.87	0.84	0.69	0.86	0.92	0.9	0.94	0.73
Net Tangible Assets	0.94	0.95	0.82	0.97	0.93	0.96		0.88	0.52	-0.94	-0.93	0.96	0.96	0.92	-0.27	0.55	0.73	0.92	0.95	0.88	0.5	0.86	0.99	0.98	0.99	0.87
Property Plant And Equipment Net	0.71	0.96	0.94	0.95	0.68	0.75	0.88		0.2	-0.8	-0.97	0.93	0.87	0.99	-0.36	0.19	0.62	0.64	0.91	0.79	0.1	0.64	0.89	0.93	0.91	1.0
Current Deferred Revenue	0.68	0.41	0.1	0.38	0.7	0.64	0.52	0.2		-0.51	-0.36	0.48	0.49	0.29	-0.13	0.58	0.66	0.73	0.48	0.54	0.74	0.76	0.54	0.47	0.51	0.2
Net Debt	-0.92	-0.89	-0.71	-0.88	-0.92	-0.87	-0.94	-0.8	-0.51		0.88	-0.88	-0.99	-0.83	0.44	-0.67	-0.65	-0.89	-0.85	-0.87	-0.37	-0.87	-0.94	-0.94	-0.92	-0.82
Retained Earnings	-0.82	-0.99	-0.85	-0.95	-0.79	-0.82	-0.93	-0.97	-0.36	0.88		-0.97	-0.93	-0.96	0.49	-0.28	-0.68	-0.76	-0.93	-0.88	-0.22	-0.78	-0.94	-0.98	-0.95	-0.98
Accounts Payable	0.88	0.99	0.82	0.96	0.87	0.89	0.96	0.93	0.48	-0.88	-0.97		0.93	0.95	-0.38	0.35	0.8	0.84	0.98	0.88	0.41	0.86	0.98	0.99	0.98	0.93
Cash	0.92	0.94	0.77	0.92	0.91	0.89	0.96	0.87	0.49	-0.99	-0.93	0.93		0.89	-0.45	0.59	0.68	0.88	0.9	0.88	0.35	0.87	0.97	0.97	0.96	0.88
Non Current Assets Total	0.77	0.96	0.95	0.98	0.74	0.81	0.92	0.99	0.29	-0.83	-0.96	0.95	0.89		-0.27	0.29	0.67	0.7	0.93	0.8	0.21	0.67	0.93	0.95	0.94	0.98
Non Currrent Assets Other	-0.3	-0.45	-0.05	-0.22	-0.28	-0.14	-0.27	-0.36	-0.13	0.44	0.49	-0.38	-0.45	-0.27		0.11	-0.2	-0.25	-0.3	-0.49	0.18	-0.49	-0.31	-0.42	-0.32	-0.43
Other Assets	0.65	0.32	0.29	0.42	0.68	0.63	0.55	0.19	0.58	-0.67	-0.28	0.35	0.59	0.29	0.11		0.32	0.69	0.34	0.41	0.5	0.52	0.53	0.43	0.48	0.2
Long Term Debt	0.77	0.73	0.52	0.65	0.76	0.68	0.73	0.62	0.66	-0.65	-0.68	0.8	0.68	0.67	-0.2	0.32		0.74	0.83	0.7	0.51	0.82	0.8	0.73	0.72	0.6
Cash And Short Term Investments	0.99	0.8	0.54	0.8	0.99	0.95	0.92	0.64	0.73	-0.89	-0.76	0.84	0.88	0.7	-0.25	0.69	0.74		0.83	0.85	0.74	0.94	0.89	0.86	0.89	0.63
Common Stock Total Equity	0.87	0.96	0.81	0.93	0.85	0.87	0.95	0.91	0.48	-0.85	-0.93	0.98	0.9	0.93	-0.3	0.34	0.83	0.83		0.83	0.43	0.83	0.96	0.96	0.96	0.89
Common Stock Shares Outstanding	0.9	0.89	0.64	0.84	0.88	0.84	0.88	0.79	0.54	-0.87	-0.88	0.88	0.88	0.8	-0.49	0.41	0.7	0.85	0.83		0.42	0.87	0.87	0.9	0.88	0.8
Short Term Investments	0.65	0.32	0.05	0.36	0.68	0.69	0.5	0.1	0.74	-0.37	-0.22	0.41	0.35	0.21	0.18	0.5	0.51	0.74	0.43	0.42		0.63	0.45	0.38	0.46	0.07
Non Current Liabilities Total	0.94	0.83	0.45	0.73	0.94	0.86	0.86	0.64	0.76	-0.87	-0.78	0.86	0.87	0.67	-0.49	0.52	0.82	0.94	0.83	0.87	0.63		0.87	0.86	0.85	0.65
Other Current Assets	0.93	0.96	0.82	0.95	0.92	0.92	0.99	0.89	0.54	-0.94	-0.94	0.98	0.97	0.93	-0.31	0.53	0.8	0.89	0.96	0.87	0.45	0.87		0.98	0.98	0.89
Other Stockholder Equity	0.9	0.99	0.82	0.97	0.89	0.9	0.98	0.93	0.47	-0.94	-0.98	0.99	0.97	0.95	-0.42	0.43	0.73	0.86	0.96	0.9	0.38	0.86	0.98		0.99	0.94
Total Liab	0.92	0.97	0.82	0.97	0.91	0.94	0.99	0.91	0.51	-0.92	-0.95	0.98	0.96	0.94	-0.32	0.48	0.72	0.89	0.96	0.88	0.46	0.85	0.98	0.99		0.9
Property Plant And Equipment Gross	0.71	0.96	0.92	0.94	0.68	0.73	0.87	1.0	0.2	-0.82	-0.98	0.93	0.88	0.98	-0.43	0.2	0.6	0.63	0.89	0.8	0.07	0.65	0.89	0.94	0.9

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.6B	5.6B	8.6B	6.4B	5.8B	3.2B
Other Current Liab	152.7M	127.8M	480.0M	114.3M	784.4M	823.6M
Other Liab	57.1M	443.3M	562.5M	283.7M	326.3M	342.6M
Net Tangible Assets	956.3M	3.9B	6.2B	4.3B	5.0B	5.2B
Net Debt	(340.7M)	(820.0M)	(3.7B)	(3.0B)	(2.3B)	(2.1B)
Retained Earnings	(2.0B)	(3.6B)	(5.0B)	(7.1B)	(8.0B)	(7.6B)
Accounts Payable	122.5M	232.0M	262.4M	294.8M	315.1M	330.9M
Cash	618.0M	1.4B	4.4B	3.9B	3.2B	3.3B
Other Assets	108.7M	186.8M	8.6B	819.9M	2.0	1.9
Long Term Debt	240.7M	183.6M	202.1M	209.1M	197.6M	143.1M
Other Current Assets	85.8M	133.0M	246.2M	190.9M	205.5M	215.8M
Total Liab	633.9M	1.7B	2.4B	2.0B	2.2B	2.3B
Total Current Assets	1.2B	5.0B	7.6B	4.7B	4.2B	2.6B
Short Term Debt	10.8M	348.9M	449.5M	353.0M	710.3M	745.8M
Common Stock	79K	118K	133K	135K	155.3K	83.2K
Long Term Debt Total	189.7M	240.7M	183.6M	202.1M	232.4M	156.4M
Capital Surpluse	2.7B	2.9B	7.4B	11.2B	12.9B	13.5B
Net Receivables	72.8M	79.7M	500.2M	173.2M	395.9M	415.7M
Inventory	28.6M	89.3M	242.6M	282.3M	416.1M	436.9M

BeiGene Investors Sentiment

The influence of BeiGene's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BeiGene. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to BeiGene's public news can be used to forecast risks associated with an investment in BeiGene. The trend in average sentiment can be used to explain how an investor holding BeiGene can time the market purely based on public headlines and social activities around BeiGene. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

BeiGene's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BeiGene's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BeiGene's news discussions. The higher the estimated score, the more favorable is the investor's outlook on BeiGene.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BeiGene in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BeiGene's short interest history, or implied volatility extrapolated from BeiGene options trading.

Pair Trading with BeiGene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BeiGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will appreciate offsetting losses from the drop in the long position's value.

Moving together with BeiGene Stock

0.75

JNJ

Johnson Johnson Aggressive Push

Pair Corr

Moving against BeiGene Stock

0.52	ELYM	Eliem Therapeutics	Pair Corr
0.5	ITCI	Intracellular Th Financial Report 2nd of May 2024	Pair Corr

The ability to find closely correlated positions to BeiGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BeiGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BeiGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BeiGene to buy it.

The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BeiGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BeiGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BeiGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:

How To Invest In BeiGene

Details

Is BeiGene Stock a good investment?

Details

What is BeiGene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out BeiGene Valuation and BeiGene Correlation analysis.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA

Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(8.45)

Revenue Per Share

23.554

Quarterly Revenue Growth

0.669

Return On Assets

(0.12)

Return On Equity

(0.22)

The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene Balance Sheet Analysis From 2010 to 2024

BeiGene fundamental ratios Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BeiGene fundamental ratios Accounts

BeiGene Investors Sentiment

Pair Trading with BeiGene

Moving together with BeiGene Stock

Moving against BeiGene Stock

Complementary Tools for BeiGene Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Short Long Term Debt Total
Other Stockholder Equity	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Cash	- 0.99	Net Debt
Retained Earnings	- 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Accounts Payable	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Property Plant And Equipment Net